Total Payments
$6,705
2024 Payments
$1,919
Companies
23
Transactions
275
Payment Breakdown by Category
Food & Beverage$6,659 (99.3%)
Education$45.45 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,659 | 272 | 99.3% |
| Education | $45.45 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,170 | 65 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $806.18 | 25 | $0 (2024) |
| Alkermes, Inc. | $802.28 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $712.20 | 25 | $0 (2024) |
| ITI, Inc. | $707.18 | 24 | $0 (2023) |
| Lundbeck LLC | $560.98 | 37 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $369.19 | 14 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $358.56 | 17 | $0 (2024) |
| ABBVIE INC. | $270.52 | 15 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $143.92 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,919 | 62 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($358.56) |
| 2023 | $960.23 | 37 | ITI, Inc. ($304.07) |
| 2022 | $1,535 | 75 | Sunovion Pharmaceuticals Inc. ($549.13) |
| 2021 | $705.92 | 40 | Sunovion Pharmaceuticals Inc. ($419.33) |
| 2020 | $339.51 | 9 | Alkermes, Inc. ($166.79) |
| 2019 | $379.25 | 20 | Janssen Pharmaceuticals, Inc ($89.62) |
| 2018 | $626.72 | 27 | Otsuka America Pharmaceutical, Inc. ($250.84) |
| 2017 | $239.35 | 5 | GlaxoSmithKline, LLC. ($94.83) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $6.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $21.58 | General |
| 10/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $120.12 | General |
| Category: CNS | ||||||
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.37 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $20.75 | General |
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: PSYCHIATRY | ||||||
| 10/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: PSYCHIATRY | ||||||
| 09/23/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.56 | General |
| 09/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Sheila Cai, MD
Dr. Sheila Cai, MD is a Psychiatry healthcare provider based in San Marcos, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780625012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheila Cai, MD has received a total of $6,705 in payments from pharmaceutical and medical device companies, with $1,919 received in 2024. These payments were reported across 275 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($6,659).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Child & Adolescent Psychiatry
- Location San Marcos, CA
- Active Since 06/09/2006
- Last Updated 09/17/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1780625012
Products in Payments
- LATUDA (Drug) $1,170
- CAPLYTA (Drug) $1,066
- REXULTI (Drug) $739.93
- INVEGA SUSTENNA (Drug) $583.10
- ARISTADA (Drug) $487.62
- VRAYLAR (Drug) $360.37
- ABILIFY MAINTENA (Drug) $354.16
- LYBALVI (Drug) $232.51
- Qelbree (Drug) $224.24
- QELBREE (Drug) $144.95
- VOQUEZNA (Drug) $125.00
- FANAPT (Drug) $120.08
- TRINTELLIX (Drug) $102.84
- SPRAVATO (Drug) $97.97
- BEXSERO (Biological) $94.83
- Auvelity (Drug) $94.14
- Aristada 441 mg (Drug) $60.73
- VYVANSE (Drug) $53.51
- AUSTEDO (Drug) $52.14
- QUVIVIQ (Drug) $48.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Marcos
Dr. Alan Berkowitz, Md, MD
Psychiatry — Payments: $13,876
Psychiatry $13,876
Dr. Paul Whitelock, M.d, M.D
Psychiatry — Payments: $5,389
Psychiatry $5,389
Dr. Josefa Licas, M.d, M.D
Psychiatry — Payments: $5,218
Psychiatry $5,218
Dr. Garrick Tong, M.d, M.D
Psychiatry — Payments: $2,948
Psychiatry $2,948
Mr. Arvin Mirow, Md, MD
Psychiatry — Payments: $2,734
Psychiatry $2,734
Mr. Dennis Ordas, Md, MD
Psychiatry — Payments: $2,205
Psychiatry $2,205